VERADIGM INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 26 rows in 2006. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2006-12-21: Reporting owner TULLMAN GLEN; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2006-12-04: Reporting owner COMPTON ROBERT A; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2006-11-29: Reporting owner HUSAIN FAZLE M; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2006-11-14: Reporting owner GOLDSTEIN BERNARD; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2006-12-21 | TULLMAN GLEN Officer (Chief Executive Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −17,000 54,111 owned after | $5.63 exercise price | 2006-12-22 | |
| 2006-12-04 | COMPTON ROBERT A Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −25,000 0 owned after | $8.69 exercise price | 2006-12-06 | |
| 2006-11-29 | HUSAIN FAZLE M Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −45,000 0 owned after | $3.53 exercise price | 2006-12-01 | |
| 2006-11-14 | GOLDSTEIN BERNARD Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 10,000 owned after | $3.45 exercise price | 2006-11-15 | |
| 2006-11-13 | GOLDSTEIN BERNARD Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 15,000 owned after | $3.45 exercise price | 2006-11-14 | |
| 2006-11-10 | GOLDSTEIN BERNARD Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 20,000 owned after | $3.45 exercise price | 2006-11-14 | |
| 2006-11-09 | GOLDSTEIN BERNARD Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 25,000 owned after | $3.45 exercise price | 2006-11-14 | |
| 2006-11-08 | GOLDSTEIN BERNARD Director | 4 | Stock option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 30,000 owned after | $3.45 exercise price | 2006-11-13 | |
| 2006-09-05 | CULL JOHN G Officer (President, Medication Services) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 0 owned after | $0.06 exercise price | 2006-09-07 | |
| 2006-09-05 | CULL JOHN G Officer (President, Medication Services) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,166 0 owned after | $3.00 exercise price | 2006-09-07 | |
| 2006-08-11 | COMPTON ROBERT A Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −15,000 35,000 owned after | $2.77 exercise price | 2006-08-15 | |
| 2006-08-04 | Green Philip D Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,800 15,200 owned after | $5.63 exercise price | 2006-08-08 | |
| 2006-08-04 | DAVIS WILLIAM J Officer (Chief Financial Officer) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −90,000 40,000 owned after | $3.04 exercise price | 2006-08-08 | |
| 2006-08-04 | MCGRAW LAURIE Officer (President, Clinical Solutions) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,666 0 owned after | $2.00 exercise price | 2006-08-08 | |
| 2006-08-04 | MCGRAW LAURIE Officer (President, Clinical Solutions) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −80,000 120,000 owned after | $3.53 exercise price | 2006-08-08 | |
| 2006-08-04 | TULLMAN GLEN Officer (Chief Executive Officer) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −118,250 0 owned after | $0.06 exercise price | 2006-08-08 | |
| 2006-08-04 | TULLMAN GLEN Officer (Chief Executive Officer) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −11,898 0 owned after | $0.06 exercise price | 2006-08-08 | |
| 2006-08-04 | CAREY JOSEPH E Officer (Chief Operating Officer) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −130,000 145,000 owned after | $3.53 exercise price | 2006-08-08 | |
| 2006-08-04 | SHAPIRO LEE Officer (President) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −25,000 0 owned after | $3.15 exercise price | 2006-08-08 | |
| 2006-08-04 | SHAPIRO LEE Officer (President) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −95,000 180,000 owned after | $3.53 exercise price | 2006-08-08 | |
| 2006-06-02 | Thierer Mark Officer (President, Physicians Interact) | 4 | Stock Option (right to buy) Derivative · Direct | X Exercise of in-the-money or at-the-money derivative security | −112,300 0 owned after | $7.73 exercise price | 2006-06-06 | |
| 2006-06-02 | Thierer Mark Officer (President, Physicians Interact) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,250 12,500 owned after | $10.25 exercise price | 2006-06-06 | |
| 2006-06-02 | Thierer Mark Officer (President, Physicians Interact) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −16,666 0 owned after | $10.67 exercise price | 2006-06-06 | |
| 2006-05-30 | Thierer Mark Officer (President, Physicians Interact) | 4 | Stock Option (right to buy) Derivative · Direct | X Exercise of in-the-money or at-the-money derivative security | −200 74,800 owned after | $7.73 exercise price | 2006-06-01 | |
| 2006-04-26 holding as of filing | Thierer Mark Officer (President, Physicians Interact) | 3 | Stock Option Derivative · Direct | Holding | $7.73 exercise price | 2006-04-26 | ||
| 2006-04-26 holding as of filing | Thierer Mark Officer (President, Physicians Interact) | 3 | Stock Option Derivative · Direct | Holding | $7.73 exercise price | 2006-04-26 |